Trial to study the safety, pharmacokinetics and preliminary antitumour activity of ODM-216 in patients with cancer

Status

Not yet recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525864-17-00

Enrollment

104

Registered

2026-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumours

None listed

Sex/Gender

All

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Aug 7, 2026